KELLIE ROGERO: Open Payments
NPI 1952148629 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,343 in 66 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $522 · 2025 $1,343
Food & beverage: $1,343
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $259 |
| SCPHARMACEUTICALS INC. | 11 | $221 |
| Novartis Pharmaceuticals Corporation | 12 | $150 |
| Merck Sharp & Dohme LLC | 10 | $149 |
| E.R. Squibb & Sons, L.L.C. | 7 | $112 |
| Alnylam Pharmaceuticals Inc. | 4 | $111 |
| PFIZER INC. | 4 | $77 |
| Philips North America LLC | 4 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
Products named: FUROSCIX, LEQVIO, VERQUVO, COREVALVE EVOLUT R, CAMZYOS, AMVUTTRA, SYMPLICITY G3, Ambulatory Monitoring & Diagnostics Undivided.
Industry payments across AL — which companies pay providers there.
